Pfizer company reported the following information as of December 31, 2016:

• Net income, $500,000
• Number of issued common shares, 225,000 shares
• Common stock (par value of $2 per share), $450,000
• Number of authorized common shares, 400,000
• Number of treasury shares, 25,000
• No shares were issued or repurchased during 2016.

How much would Pfizer report as its earnings-per-share (EPS) for 2016?

If Pfizer repurchases 30,000 additional shares of treasury stock during 2017, what would be the number of shares outstanding as of December 31, 2017? Assume that no additional shares were issued during 2017.